Olanzapine-Based Triple Regimens Versus Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta-Analysis
The oncologist, 2018.
Chemotherapy‐induced nausea and vomitingHighly emetogenic chemotherapyNauseaNetwork meta‐analysisNeurokinin‐1 receptor antagonistsMore(1+)
The current antiemetic prophylaxis for patients treated with highly emetogenic chemotherapy (HEC) included the olanzapine-based triplet and neurokinin-1 receptor antagonists (NK-1RAs)-based triplet. However, which one shows better antiemetic effect remained unclear.We systematically reviewed 43 trials, involving 16,609 patients with HEC, ...More
Full Text (Upload PDF)
PPT (Upload PPT)